Copper nanoparticles (Cu-NPs) have been used more and more in varied merchandise and functions. Though latest research have reported that publicity to Cu-NPs results in organ accumulation and apparent toxicity, it stays unclear whether or not Cu-NPs will be translocated to and trigger injury within the uterus. On this examine, we investigated the potential for uterine harm and gene expression patterns in feminine rats uncovered to three.12, 6.25, or 12.5 mg/kg/d Cu-NPs through intraperitoneal injection for <em>14</em> consecutive days. The outcomes indicated that publicity to Cu-NPs led to vital decreases within the relative uterine weight coefficients and will increase in inflammatory cell infiltration, mitochondrial swelling and vacuolization, shortened and lowered endometrial epithelial cell microvilli, and apoptosis.
Moreover, publicity to Cu-NPs elevated malondialdehyde (MDA) accumulation and decreased superoxide dismutase (SOD) ranges. Sign transduction mechanism research indicated that publicity to Cu-NPs activated <em>caspases</em> 3, 8, and 9 and BH3 interacting area dying agonist (tBid), lowered B cell leukemia/lymphoma 2 (Bcl-2) expression, and elevated the expression of apoptotic peptidase activating issue 1 (Apaf-1), BCL2-associated X, apoptosis regulator (Bax), and cytochrome c. A microarray evaluation revealed vital alterations within the expression of 963 genes; of those, 622 had been upregulated and 341 had been downregulated. The outcomes of additional evaluations of some altered genes, together with matrix metallopeptidase 12 (Mmp12), utilizing quantitative RT-PCR agreed with the microarray findings. These outcomes present sturdy proof that Cu-NPs can set off each intrinsic and extrinsic apoptotic pathways to mediate uterine harm, leading to oxidative stress-related modifications in gene expression.
Beforehand, we confirmed that noxious stimulation of the tail produces quite a few detrimental results after spinal wire harm (SCI), together with an earlier onset and elevated magnitude of mechanical hypersensitivity. Increasing on these observations, this examine sought to find out whether or not localized peripheral irritation equally impacts the expression of mechanical hypersensitivity after SCI.
The Impact of Lengthy-Time period Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism within the Coronary heart of Rats with Main and Secondary Hypertension.
Fatty acid amide hydrolase (FAAH) inhibitor [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate (URB597) might affect redox stability and blood stress by means of the modulation of endocannabinoids ranges. Due to this fact, this examine aimed to check modifications in oxidative metabolism and apoptosis within the hearts of rats with spontaneous hypertension (SHR) and secondary hypertension (11-deoxycorticosterone acetate; DOCA-salt rats) handled by URB597 through intraperitoneal injection for days. The outcomes confirmed that URB597 decreased the exercise of NADPH and xanthine oxidases in each teams of rats. Furthermore, within the coronary heart of SHR rats, URB597 led to a rise of enzymatic and nonenzymatic antioxidant exercise and ranges (catalase, vitamin C, glutathione/glutathione disulfide [GSH/GSSG]) and upregulation of the thioredoxin system; nonetheless, NRf2 expression was downregulated.
The alternative impact in relation to Nrf2 exercise and the thioredoxin system was noticed in DOCA-salt rats after URB597 administration. Regardless of enchancment in antioxidant parameters, URB597 enhanced oxidative modifications of phospholipids (4-hydroxynonenal and isoprostanes) and proteins (carbonyl teams) in SHR coronary heart, whereas 4-hydroxynonenal and carbonyl teams ranges decreased within the coronary heart of DOCA-salt rats. Obtained outcomes recommend that examined lipid mediators are concerned in peroxisome proliferator-activated receptors (PPAR)-independent and PPAR-dependent modulation of cardiac inflammatory reactions. Moreover, decreased expression of pro-apoptotic proteins (Bax and <em>caspase</em> Three and 9) was noticed after URB597 administration within the coronary heart of each teams of hypertensive rats, whereas expression of the antiapoptotic protein (Bcl-2) elevated in SHR rats.
Lengthy-term administration of URB597 altered cardiac redox standing relying on the kind of hypertension. URB597 enhanced oxidative metabolism and lowered pro-apoptotic components within the coronary heart of SHR rats, rising the chance of coronary heart metabolic issues prevalence or development.
Self-nanoemulsifying drug-delivery programs for potentiated anti-inflammatory exercise of diacerein.
UNASSIGNED
Efficient therapy of osteoarthritis necessitates each symptomatic aid and hindrance of joint degeneration development. Non-steroidal anti-inflammatory medicine allow symptomatic aid solely and might trigger mucosal harm within the intestine. Earlier than absorption, diacerein (Dcn) is transformed into rhein that counteracts cartilage degeneration with out affecting prostaglandin manufacturing. But, low solubility and laxative motion of unabsorbed rhein within the colon hindered its use. Thus, enhanced Dcn dissolution would enable absorption on the higher intestine bettering its bioavailability and probably abolishing the laxative motion.
UNASSIGNED
Due to this fact, self-nanoemulsifying drug supply programs (SNEDDSs) with every of gelucire (Glc) and d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) at totally different drug:service weight ratios of 1:1, 1:2, 1:4, 1:6, 1:Eight and 1:10 had been ready by soften methodology and crammed into arduous gelatin capsules. The optimized binary programs had been chosen primarily based on strong state characterization, scanning electron microscopy (SEM) and in vitro analysis of the ready SNEDDSs as compared with their corresponding bodily mixtures (PMs) and Dcn. The optimized programs had been additional examined with respect to their morphology, measurement distribution and ζ-potential. Furthermore, the anti-inflammatory exercise of the optimized programs towards carrageenan-induced paw edema in rats was assessed by means of estimation of edema and edema inhibition percentages in addition to histopathological examination and immunohistochemical localization of tumor necrosis factor-alpha (TNF-α) and <em>caspase</em>-3.
UNASSIGNED
Considerably (P<0.05) enhanced in vitro drug launch was recorded for SNEDDSs with both service when in comparison with Dcn and the corresponding PMs. SNEDDSs primarily based on 1:10 Dcn:Glc and 1:Eight Dcn:TPGS confirmed considerably (P<0.05) lowered edema and irritation in addition to expression of TNF-α and caspase-Three relative to constructive management and Dcn pretreated teams.
 FAM FLICA CASPASE-9 KIT |
|
MBS239190-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
FAM FLICA CASPASE-9 KIT |
|
MBS239190-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
FAM FLICA CASPASE-9 KIT |
|
MBS239219-25Tests |
MyBiosource |
25Tests |
EUR 465 |
FAM FLICA CASPASE-9 KIT |
|
MBS239219-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
 FAM FLICA CASPASE-1 KIT |
|
GWB-Q00437 |
GenWay Biotech |
25 TESTS |
Ask for price |
FAM FLICA CASPASE-1 KIT |
|
GWB-Q00438 |
GenWay Biotech |
100 TESTS |
Ask for price |
 FAM FLICA CASPASE-2 KIT |
|
GWB-Q00441 |
GenWay Biotech |
25 TESTS |
Ask for price |
FAM FLICA CASPASE-2 KIT |
|
GWB-Q00442 |
GenWay Biotech |
100 TESTS |
Ask for price |
 FAM FLICA CASPASE-6 KIT |
|
GWB-Q00445 |
GenWay Biotech |
25 TESTS |
Ask for price |
FAM FLICA CASPASE-6 KIT |
|
GWB-Q00446 |
GenWay Biotech |
100 TESTS |
Ask for price |
 FAM FLICA CASPASE-8 KIT |
|
GWB-Q00447 |
GenWay Biotech |
25 TESTS |
Ask for price |
FAM FLICA CASPASE-8 KIT |
|
GWB-Q00448 |
GenWay Biotech |
100 TESTS |
Ask for price |
FAM FLICA CASPASE-8 KIT |
|
MBS239170-25Tests |
MyBiosource |
25Tests |
EUR 465 |
FAM FLICA CASPASE-8 KIT |
|
MBS239170-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
FAM FLICA CASPASE-6 KIT |
|
MBS239171-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
FAM FLICA CASPASE-6 KIT |
|
MBS239171-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
FAM FLICA CASPASE-1 KIT |
|
MBS239178-25Tests |
MyBiosource |
25Tests |
EUR 495 |
FAM FLICA CASPASE-1 KIT |
|
MBS239178-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2260 |
FAM FLICA CASPASE-6 KIT |
|
MBS239192-25Tests |
MyBiosource |
25Tests |
EUR 465 |
FAM FLICA CASPASE-6 KIT |
|
MBS239192-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
FAM FLICA CASPASE-8 KIT |
|
MBS239195-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
FAM FLICA CASPASE-8 KIT |
|
MBS239195-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
FAM FLICA CASPASE-1 KIT |
|
MBS239202-100Tests |
MyBiosource |
100Tests |
EUR 1185 |
FAM FLICA CASPASE-1 KIT |
|
MBS239202-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5490 |
FAM FLICA CASPASE-2 KIT |
|
MBS239214-25Tests |
MyBiosource |
25Tests |
EUR 465 |
FAM FLICA CASPASE-2 KIT |
|
MBS239214-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
 FAM FLICA CASPASE-10 KIT |
|
GWB-Q00440 |
GenWay Biotech |
100 TESTS |
Ask for price |
FAM FLICA CASPASE-10 KIT |
|
MBS239207-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
FAM FLICA CASPASE-10 KIT |
|
MBS239207-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
 FAM FLICA CASPASE-3/7 KIT |
|
GWB-Q00443 |
GenWay Biotech |
25 TESTS |
Ask for price |
FAM FLICA CASPASE-3/7 KIT |
|
GWB-Q00444 |
GenWay Biotech |
100 TESTS |
Ask for price |
FAM FLICA CASPASE-3/7 KIT |
|
MBS239174-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
FAM FLICA CASPASE-3/7 KIT |
|
MBS239174-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
FAM FLICA CASPASE-3/7 KIT |
|
MBS239216-25Tests |
MyBiosource |
25Tests |
EUR 465 |
FAM FLICA CASPASE-3/7 KIT |
|
MBS239216-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
 FAM FLICA POLY CASPASE KIT |
|
GWB-Q00451 |
GenWay Biotech |
25 TESTS |
Ask for price |
FAM FLICA POLY CASPASE KIT |
|
GWB-Q00452 |
GenWay Biotech |
100 TESTS |
Ask for price |
FAM FLICA POLY CASPASE KIT |
|
MBS239189-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
FAM FLICA POLY CASPASE KIT |
|
MBS239189-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
FAM FLICA POLY CASPASE KIT |
|
MBS239204-25Tests |
MyBiosource |
25Tests |
EUR 465 |
FAM FLICA POLY CASPASE KIT |
|
MBS239204-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
) FAM FLICA CASPASE-10 KIT (OKSA11285) |
|
OKSA11285 |
Aviva Systems Biology |
100 Tests |
EUR 1875.6 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-10 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICA CASPASE-1 KIT (OKSA11274) |
|
OKSA11274 |
Aviva Systems Biology |
25 Tests |
EUR 709.2 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-1 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICA CASPASE-1 KIT (OKSA11275) |
|
OKSA11275 |
Aviva Systems Biology |
100 Tests |
EUR 1827.6 |
|
Description: Description of target: The FAM FLICATM Capase 1 kit uses a target sequence (YVAD) sandwiched between a green fluorescent label, FAM, and FMK to make a quick and flexible method to analyze active capases in apoptotic cells. These kits measure apoptosis by detecting active caspases in whole, living cells. They don't work by using antibodies or an ELISA. Instead, their methodology is based a unique cell-permeable and non-cytotoxic reagent called Fluorochrome Inhibitor of Caspases. These kits are suitable for cells in suspension, adherent cells, thin tissue sections (but not fixed or paraffin-embedded cells) from many species including mammalian, insect, and yeast. Different cell types, e.g. HeLa, primary neurons, macrophages and lymphocytes have also been successfully studied with these kits. ;Species reactivity: Human;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICA CASPASE-2 KIT (OKSA11283) |
|
OKSA11283 |
Aviva Systems Biology |
100 Tests |
EUR 1593.6 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-2 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICA CASPASE-3/7 KIT (OKSA11271) |
|
OKSA11271 |
Aviva Systems Biology |
100 Tests |
EUR 1828.8 |
|
Description: Description of target: The FAM FLICA™ Caspase 3 & 7 kit uses a quick and easy method to analyze active caspases in apoptotic cells.;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
 SR FLICA CASPASE-9 KIT |
|
GWB-Q00475 |
GenWay Biotech |
25 TESTS |
Ask for price |
SR FLICA CASPASE-9 KIT |
|
GWB-Q00476 |
GenWay Biotech |
100 TESTS |
Ask for price |
SR FLICA CASPASE-9 KIT |
|
MBS239176-25Tests |
MyBiosource |
25Tests |
EUR 465 |
SR FLICA CASPASE-9 KIT |
|
MBS239176-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
SR FLICA CASPASE-9 KIT |
|
MBS239212-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
SR FLICA CASPASE-9 KIT |
|
MBS239212-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
) FAM FLICAâ„¢ CASPASE-9 KIT (OKSA11278) |
|
OKSA11278 |
Aviva Systems Biology |
25 Tests |
EUR 709.2 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-9 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICAâ„¢ CASPASE-9 KIT (OKSA11279) |
|
OKSA11279 |
Aviva Systems Biology |
100 Tests |
EUR 1828.8 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-9 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
 FLICA 660 Caspase-1 Kit |
|
MBS225369-2550Tests |
MyBiosource |
25-50Tests |
EUR 535 |
FLICA 660 Caspase-1 Kit |
|
MBS225369-5x2550Tests |
MyBiosource |
5x25-50Tests |
EUR 2450 |
 FLICA 660 Poly Caspase Kit |
|
MBS225840-2550Tests |
MyBiosource |
25-50Tests |
EUR 535 |
FLICA 660 Poly Caspase Kit |
|
MBS225840-5x2550Tests |
MyBiosource |
5x25-50Tests |
EUR 2450 |
 FLICA 660 Caspase-3/7 Kit |
|
MBS225370-2550Tests |
MyBiosource |
25-50Tests |
EUR 535 |
FLICA 660 Caspase-3/7 Kit |
|
MBS225370-5x2550Tests |
MyBiosource |
5x25-50Tests |
EUR 2450 |
 FLICA 660 Caspase-1 Assay Kit |
|
MBS258044-2550Tests |
MyBiosource |
25-50Tests |
EUR 355 |
 SR FLICA POLY CASPASE KIT |
|
GWB-Q00477 |
GenWay Biotech |
25 TESTS |
Ask for price |
SR FLICA POLY CASPASE KIT |
|
GWB-Q00478 |
GenWay Biotech |
100 TESTS |
Ask for price |
SR FLICA POLY CASPASE KIT |
|
MBS239210-25Tests |
MyBiosource |
25Tests |
EUR 465 |
SR FLICA POLY CASPASE KIT |
|
MBS239210-5x25Tests |
MyBiosource |
5x25Tests |
EUR 2120 |
SR FLICA POLY CASPASE KIT |
|
MBS239213-100Tests |
MyBiosource |
100Tests |
EUR 1110 |
SR FLICA POLY CASPASE KIT |
|
MBS239213-5x100Tests |
MyBiosource |
5x100Tests |
EUR 5145 |
 SR FLICA Caspase 8 Assay Kit |
|
MBS258048-100Tests |
MyBiosource |
100Tests |
EUR 705 |
SR FLICA Caspase 8 Assay Kit |
|
MBS258048-25Tests |
MyBiosource |
25Tests |
EUR 320 |
SR FLICA Caspase 8 Assay Kit |
|
MBS258048-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
) FAM FLICAâ„¢ CASPASE-6 KIT (OKSA11272) |
|
OKSA11272 |
Aviva Systems Biology |
25 Tests |
EUR 717.6 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-6 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICAâ„¢ CASPASE-6 KIT (OKSA11273) |
|
OKSA11273 |
Aviva Systems Biology |
100 Tests |
EUR 1860 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-6 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICAâ„¢ CASPASE-8 KIT (OKSA11276) |
|
OKSA11276 |
Aviva Systems Biology |
25 Tests |
EUR 709.2 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-8 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICAâ„¢ CASPASE-8 KIT (OKSA11277) |
|
OKSA11277 |
Aviva Systems Biology |
100 Tests |
EUR 1828.8 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-8 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICAâ„¢ CASPASE-2 KIT (OKSA11282) |
|
OKSA11282 |
Aviva Systems Biology |
25 Tests |
EUR 668.4 |
|
Description: Description of target: FAM FLICAâ„¢ CASPASE-2 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
 FLICA 660 Poly Caspase Assay Kit |
|
MBS258017-2550Tests |
MyBiosource |
25-50Tests |
EUR 355 |
 FAM-FLICA Caspase 9 Assay Kit |
|
MBS258024-100Tests |
MyBiosource |
100Tests |
EUR 705 |
FAM-FLICA Caspase 9 Assay Kit |
|
MBS258024-25Tests |
MyBiosource |
25Tests |
EUR 320 |
FAM-FLICA Caspase 9 Assay Kit |
|
MBS258024-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
) FAM FLICAâ„¢ POLY CASPASE KIT (OKSA11268) |
|
OKSA11268 |
Aviva Systems Biology |
25 Tests |
EUR 709.2 |
|
Description: Description of target: FAM FLICAâ„¢ POLY CASPASE KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) FAM FLICAâ„¢ POLY CASPASE KIT (OKSA11269) |
|
OKSA11269 |
Aviva Systems Biology |
100 Tests |
EUR 1828.8 |
|
Description: Description of target: FAM FLICAâ„¢ POLY CASPASE KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
 FLICA 660 Caspase 3/7 Assay Kit |
|
MBS258001-2550Tests |
MyBiosource |
25-50Tests |
EUR 355 |
 SR FLICA Caspase 3 and 7 Assay Kit |
|
MBS258021-100Tests |
MyBiosource |
100Tests |
EUR 705 |
SR FLICA Caspase 3 and 7 Assay Kit |
|
MBS258021-25Tests |
MyBiosource |
25Tests |
EUR 320 |
SR FLICA Caspase 3 and 7 Assay Kit |
|
MBS258021-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
 FAM-FLICA Caspase 2 Assay Kit |
|
MBS258004-100Tests |
MyBiosource |
100Tests |
EUR 705 |
FAM-FLICA Caspase 2 Assay Kit |
|
MBS258004-25Tests |
MyBiosource |
25Tests |
EUR 320 |
FAM-FLICA Caspase 2 Assay Kit |
|
MBS258004-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
 FAM-FLICA Caspase 8 Assay Kit |
|
MBS258011-100Tests |
MyBiosource |
100Tests |
EUR 705 |
FAM-FLICA Caspase 8 Assay Kit |
|
MBS258011-25Tests |
MyBiosource |
25Tests |
EUR 320 |
FAM-FLICA Caspase 8 Assay Kit |
|
MBS258011-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
 FAM-FLICA Caspase 6 Assay Kit |
|
MBS258019-100Tests |
MyBiosource |
100Tests |
EUR 705 |
FAM-FLICA Caspase 6 Assay Kit |
|
MBS258019-25Tests |
MyBiosource |
25Tests |
EUR 320 |
FAM-FLICA Caspase 6 Assay Kit |
|
MBS258019-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
 FAM-FLICA Caspase 10 Assay Kit |
|
MBS258025-100Tests |
MyBiosource |
100Tests |
EUR 705 |
FAM-FLICA Caspase 10 Assay Kit |
|
MBS258025-25Tests |
MyBiosource |
25Tests |
EUR 320 |
FAM-FLICA Caspase 10 Assay Kit |
|
MBS258025-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
 FAM-FLICA Caspase 1 Assay Kit |
|
MBS258406-100Tests |
MyBiosource |
100Tests |
EUR 740 |
FAM-FLICA Caspase 1 Assay Kit |
|
MBS258406-25Tests |
MyBiosource |
25Tests |
EUR 335 |
FAM-FLICA Caspase 1 Assay Kit |
|
MBS258406-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3410 |
 FAM-FLICA Poly Caspase Assay Kit |
|
MBS258010-100Tests |
MyBiosource |
100Tests |
EUR 705 |
FAM-FLICA Poly Caspase Assay Kit |
|
MBS258010-25Tests |
MyBiosource |
25Tests |
EUR 320 |
FAM-FLICA Poly Caspase Assay Kit |
|
MBS258010-5x100Tests |
MyBiosource |
5x100Tests |
EUR 3255 |
) SR FLICAâ„¢ CASPASE-9 KIT (OKSA11301) |
|
OKSA11301 |
Aviva Systems Biology |
25 Tests |
EUR 724.8 |
|
Description: Description of target: SR FLICAâ„¢ CASPASE-9 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
) SR FLICAâ„¢ CASPASE-9 KIT (OKSA11302) |
|
OKSA11302 |
Aviva Systems Biology |
100 Tests |
EUR 1884 |
|
Description: Description of target: SR FLICAâ„¢ CASPASE-9 KIT;Species reactivity: ;Application: FC, IF;Assay info: ;Sensitivity: |
 FAM-FLICA Caspase 3 & 7 Assay Kit |
|
MBS258028-100Tests |
MyBiosource |
100Tests |
EUR 705 |
UNASSIGNED
These SNEDDSs will be represented as potential oral drug supply programs of Dcn for enhanced dissolution and anti inflammatory exercise towards carrageenan-induced paw edema.
